CME vs MSCI
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
CME
MSCI
Investment Advisor Scores
MSCI
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CME | MSCI | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 23.6407 | 28.9017 | CME |
| PEG Ratio | 4.218 | 2.0192 | MSCI |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 13.0% | 12.4% | CME |
| Earnings Growth | 16.1% | 14.4% | CME |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 44.1/100 | 35.1/100 | CME |
| Profit Margin | 63.5% | 40.3% | CME |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | CME |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CME
MarkupPrice above SMA50, rising 50-day trend (4.3% over 20 days), RSI 71
MSCI
MarkupPrice above SMA50, rising 50-day trend (3.9% over 20 days), RSI 68
Fundamentals Snapshot
| Metric | CME | MSCI |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 23.9 | 29.5 |
| Trailing P/E | 25.0 | 34.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 1.0% | 0.8% |
| Operating Margin | 0.7% | 0.6% |
| EPS | 12.38 | 18.91 |
| Dividend Yield | 0.02% | 0.01% |